Effect of renal revascularization on the development of renal dysfunction in atherosclerotic ischemic nephropathy

Insights

Atherosclerotic renal disease (ARD) contributes to chronic kidney disease (CKD). Revascularization procedures for ARD have not shown benefits over medical treatment alone for improving renal outcomes in CKD patients.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Vascular Surgery

Background:

  • Chronic kidney disease (CKD) involves progressive renal function loss, often caused by hypertension and diabetes.
  • Atherosclerotic renal disease (ARD) is a significant cause of hypertension.
  • CKD progression in ARD may involve renal microcirculation, not just main artery blockages.

Purpose of the Study:

  • To analyze studies comparing revascularization versus medical treatment for renal outcomes in Atherosclerotic Renal Disease (ARD) patients.
  • To evaluate the evidence for angioplasty benefits in ARD patients with CKD.

Main Methods:

  • Systematic review and analysis of significant studies.
  • Comparison of renal outcomes between revascularization and medical management in ARD.
  • Assessment of evidence regarding angioplasty efficacy in ARD-related CKD.

Main Results:

  • Current evidence does not support angioplasty benefits over medical treatment alone for ARD patients.
  • Revascularization success does not consistently improve CKD progression in ARD.
  • Renal microcirculation involvement complicates treatment outcomes in ARD.

Conclusions:

  • No proven benefit of angioplasty compared to medical therapy for renal outcomes in ARD.
  • Further research is needed to clarify the role of revascularization in ARD-related CKD.
  • Understanding microcirculatory impact is crucial for managing CKD in ARD.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
525
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
2
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.6K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
567
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K